Literature DB >> 29886013

Protein Engineering Allows for Mild Affinity-based Elution of Therapeutic Antibodies.

Sara Kanje1, Raminta Venskutonytė2, Julia Scheffel1, Johan Nilvebrant1, Karin Lindkvist-Petersson2, Sophia Hober3.   

Abstract

Presented here is an engineered protein domain, based on Protein A, that displays a calcium-dependent binding to antibodies. This protein, ZCa, is shown to efficiently function as an affinity ligand for mild purification of antibodies through elution with ethylenediaminetetraacetic acid. Antibodies are commonly used tools in the area of biological sciences and as therapeutics, and the most commonly used approach for antibody purification is based on Protein A using acidic elution. Although this affinity-based method is robust and efficient, the requirement for low pH elution can be detrimental to the protein being purified. By introducing a calcium-binding loop in the Protein A-derived Z domain, it has been re-engineered to provide efficient antibody purification under mild conditions. Through comprehensive analyses of the domain as well as the ZCa-Fc complex, the features of this domain are well understood. This novel protein domain provides a very valuable tool for effective and gentle antibody and Fc-fusion protein purification.
Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Protein A; Z domain; antibody purification; calcium-dependent binding; protein engineering

Mesh:

Substances:

Year:  2018        PMID: 29886013     DOI: 10.1016/j.jmb.2018.06.004

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Mass Spectrometry-Based Methods for Immunoglobulin G N-Glycosylation Analysis.

Authors:  Siniša Habazin; Jerko Štambuk; Jelena Šimunović; Toma Keser; Genadij Razdorov; Mislav Novokmet
Journal:  Exp Suppl       Date:  2021

2.  Efficient Labeling of Native Human IgG by Proximity-Based Sortase-Mediated Isopeptide Ligation.

Authors:  Wendy Yu; Kevin P Gillespie; Bonirath Chhay; Anne-Sophie Svensson; Per-Åke Nygren; Ian A Blair; Feifan Yu; Andrew Tsourkas
Journal:  Bioconjug Chem       Date:  2021-05-24       Impact factor: 6.069

Review 3.  Modelling of pH-dependence to develop a strategy for stabilising mAbs at acidic steps in production.

Authors:  Max Hebditch; Ryan Kean; Jim Warwicker
Journal:  Comput Struct Biotechnol J       Date:  2020-03-10       Impact factor: 7.271

4.  Integrated continuous biomanufacturing on pilot scale for acid-sensitive monoclonal antibodies.

Authors:  Hubert Schwarz; Joaquín Gomis-Fons; Madelène Isaksson; Julia Scheffel; Niklas Andersson; Andreas Andersson; Andreas Castan; Anita Solbrand; Sophia Hober; Bernt Nilsson; Veronique Chotteau
Journal:  Biotechnol Bioeng       Date:  2022-05-07       Impact factor: 4.395

5.  Optimization of a calcium-dependent Protein A-derived domain for mild antibody purification.

Authors:  Julia Scheffel; Sara Kanje; Jesper Borin; Sophia Hober
Journal:  MAbs       Date:  2019-09-17       Impact factor: 5.857

Review 6.  Protein aggregation and immunogenicity of biotherapeutics.

Authors:  Ngoc B Pham; Wilson S Meng
Journal:  Int J Pharm       Date:  2020-06-09       Impact factor: 5.875

Review 7.  Affinity-Based Methods for Site-Specific Conjugation of Antibodies.

Authors:  Emma von Witting; Sophia Hober; Sara Kanje
Journal:  Bioconjug Chem       Date:  2021-08-09       Impact factor: 4.774

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.